J&J Hedges On 2025 Pharma Revenue Outlook

 
• By Jessica Merrill

The company admitted it may not meet a goal set in 2021 to reach a $60bn pharmaceutical revenue target in 2025.

missed target
J&J said it may miss a financial target it set for 2025 • Source: Shutterstock

More from Strategy

More from Business